This system is particularly interesting because the Srlv-1 locus overrides the protection against neoplasia conferred by the H-2D d allele.
Materials and Methods
Mice. B10.AQR(nS) mice were generously supplied by Dr. Jan Klein, University of Texas Southwestern Medical School, Dallas, Texas. All other mouse strains (Table II) were bred and maintained in our own colonies.
Viruses. RadLV preparations were cell-free extracts from virus-induced lymphoid tumors of C57BL/Ka mice, made as previously described (8) (9) (10) . FV preparations were kindly supplied by Dr. Frank Lilly, Albert Einstein College of Medicine, Bronx, N. Y., and Dr. Bruce Chesebro, National Institutes of Health, Rocky Mountain Laboratory, Hamilton, Mont.
Virus Inoculation and Scoring for Leukemogenesis. All animals received RadLV intrathymi-
tally at 3-6 wk of age and were scored for leukemogenesis after autopsy as described previously (8) . 
, anti-H-2K ~]
antiserum raised in our laboratory were used to H-2 genotype F2 progeny by the hemagglutination assay (8, 11) .
Virus Susceptibility Test, Mice were scored as being either susceptible or resistant at Fv-2 according to the results of the spleen focus assay (12) . Mice were injected in the tail vein with various FV dilutions and killed 9-10 days later. Their spleens were removed and weighed, fixed in Bouin's solution for about 3 h, and examined for macroscopic foci. Under these conditions, susceptible mice showed markedly enlarged spleens with many foci, whereas resistant mice showed spleens of near normal size with no or very few foci.
Results
A Single Locus, Srlv-1 Confers Dominant Susceptibility to RadLV-Induced Neoplasia. In the preceding publication (8), we showed that C57BL/10-derived congenic strains of mice carrying the H-2D d allele are resistant to RadLVinduced leukemogenesis, and that resistance is dominant. One exception to this rule is strain B10.AQR(n4). As shown in Fig. 1 , and Table I , this mouse strain is highly susceptible to the disease. In addition, [B10.AQR(n4) × B10.A)F1 [susceptible(s) × resistant(r)] mice are susceptible to RadLV=induced neoplasia, demonstrating that susceptibility is dominant.
The H-2 chromosome (H-2 ~1) carried by B10.AQR(n4) was derived by recombination in a (B10.A x T138)FI heterozygote (13, 14) . The crossover occurred between the H-2K and Ir-lA loci, such that it derived the H-2Kq allele from T138, and the Ir-lA k allele (and H-2D d allele) from B10.A. Progeny carrying the recombinant chromosome were backcrossed four times to strain B10, and then intercrossed to establish the B10.AQR(n4) line. Since 8-15 backcrosses are required to produce a truly congenic line (15) , intercrossing after only 4 backcrosses to B10 potentially fixes T138-derived alleles at loci not linked to H-2.
The first clue that a locus not linked to H-2 determined susceptibility to RadLV-induced leukemogenesis came from studies with strain B10.AQR(nS). This strain was derived from the eighth backcross generation, and would be expected to carry less of the genome foreign to the original B10 stock. Table I compares the mortality incidence of B10.AQR(nS) mice with B10.AQR(n4) animals. It is clear that the n8 generation, like other strains expressing the H-2D ~ allele, is resistant to neoplasia. This finding suggests that a locus not linked to H-2 confers susceptibility to RadLV-induced leukemogenesis, and that the dominant allele carred by B10.AQR(n4) has been lost after four additional backcrosses to B10. Formal genetic proof that a single locus determining susceptibility to the neoplasia is not linked to H-2 was achieved by segregation analysis. [B10.AQR(n4) x B10.A]F1 mice were intercrossed, and the F2 generation analyzed. Antisera specific for the H-2K q product [expressed by B10.AQR(n4)] (see Table II ) and the H-2K k produce (expressed by B10.A) (see Table II 
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* Vertical bar indicates crossover position. Table I ). For example, if it is assumed that a single, non-H-2-1inked locus confers susceptibility to RadLV, all possible 1-1-2 haplotypes, namely Yl/Yl, a/a, and yl/a, will be associated with genotypes s/s, s/r, and r/r at the non-H-2 locus (where s stands for the susceptible allele, and r for the resistant one) with a frequency of 0.25, 0.50, and 0.25, respectively. Only the r/r genotype will confer resistance, while the H-2 genotype ofF2 progeny will be irrelevant in determining resistance or susceptibility to RadLV. The leukemia incidence predicted for this mode of inheritance may be computed by mutiplying the expected genotype frequency by the leukemia incidence previously observed for this genotype (in this case it is [(0.25 × 79%) + (0.50 × 78%) + (0.25 × 19%)] --64%). The difference between the expected and observed results for each mode of inheritance was analyzed by the X 2 test (16). Data presented in Table III suggest that a single, dominant locus, which is not linked to Ho2 confers susceptibility to RadLV. We tentatively designate this locus, Srlv-1, and assign two alleles, s denoting susceptibility and r denoting resistance. (The possibility, not shown in Table III , that two genes are operative, either one of which is sufficient to confer susceptibility, may also be ruled out by similar analysis.)
The Locus Conferring Dominant Susceptibility to RadL V-Induced Leukemogenesis is not Fv-2. FV inoculation induces erythryoleukemia, the outstanding feature of which is a logarithmic increase in spleen weight, beginning almost immediately after virus inoculation (7, 17) . The splenomegaly results from the proliferation of erythrocyte precursor cells and is accompanied by the appearance of macroscopic foci on the surface of the spleen as early as 6-9 days after infection. The component of FV capable of inducing spleen foci is designated spleen focus-forming virus (SFFV). The host phenotype for SFFV is governed by the gene Fv-2, which has been mapped to chromosome 9. Fv-2 seems to play a negligible genetic role in governing the response of mice to leukemia viruses other than SFFV, probably because most other murine luekemia viruses infect nonerythroid cells. Therefore, Fv-2 probably does not affect RadLV-induced leukemogenesis. However, although strain AQR does not carry the translocation maker, it was derived from a recombination event between strains B10.A and T138, a translocation stock (13) involving chromosomes 9 and 17. Since Fv-2 is associated with chromosome 9 and confers dominant susceptibility, and since CBA which is Fv-2 ~ (susceptible) was one of the parent strains used in deriving T(2;9) 138Ca (14) , the possibility that susceptibility to RadLV in B10.AQR(n4) is due to Fv-2 was investigated.
FV was inoculated at various dilutions into BALB/c (Fv-2 ~, susceptible), B10.A(1R) (Fv-2 r, resistant) , and B10.AQR(n4). Since B10.AQR(n4) appears to be as resistant as B10.A(1R) to splenomegaly and focus formation B10.AQR(n4) mice carry the Fv-2 ~ allele (Fig. 2) . The Srlv-1 locus is thus distinct from the Fv-2 locus. Discussion B10.AQR(n4) mice are highly susceptible to RadLV-induced leukemogenesis despite carrying the H-2D ~ allele which has been shown to confer resistance to the disease (6). F2 segregation analysis and studies with B10.AQR(n8) strongly suggest that susceptibility is due to a locus not linked to the major histocompatibility complex, H-2. In addition, susceptibility is inherited in dominant fashion, [7] . The mechanism of action of Srlv-1 is presently unknown, although preliminary data indicate that it might affect virus production. These findings are suggestive of complex genetic interactions between distinct loci affecting virus-induced leukemogenesis. This is an area of great importance, which has only recently begun to be explored (7, 19) . Further studies are currently in progress to understand the mechanism of action ofSrlv-1, as well as its precise genetic localization. Summary A single locus, tentatively denoted Srlv-1 (susceptibility to radiation leukemia virus[RadLV]-l), confers dominant susceptibility to RadLV-induced leukemogenesis. Srlv-1 is not linked to H-2, and appears to be distinct from Fv-1 and Fv-2. Preliminary data suggest that Srlv-1 affects virus proliferation. A striking feature of this system is that Srlv-1 overrides the protection afforded by the H-2D-associated dominant resistance to RadLV-induced neoplasia.
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